This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dortet, L.
Right arrow Articles by Cattoir, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dortet, L.
Right arrow Articles by Cattoir, V.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2006, p. 4471-4478, Vol. 44, No. 12
0095-1137/06/$08.00+0     doi:10.1128/JCM.01535-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens{triangledown}

Laurent Dortet, Patrick Legrand, Claude-James Soussy, and Vincent Cattoir*

Laboratoire de Bactériologie-Virologie, Centre Hospitalo-Universitaire Henri-Mondor, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine, Université Paris XII, Créteil, France

Received 25 July 2006/ Returned for modification 1 September 2006/ Accepted 5 October 2006

The species belonging to the Acinetobacter genus are currently reported as opportunistic pathogens in hospitalized patients with underlying predispositions. However, except for the Acinetobacter calcoaceticus-Acinetobacter baumannii complex, the identification of other species is frequently unreliable, especially for Acinetobacter ursingii and Acinetobacter schindleri, newly described in 2001. Thus, the clinical significance, phenotypic features, and antimicrobial susceptibilities of these two misidentified species remain unclear. Of 456 Acinetobacter sp. clinical strains isolated from 2002 to 2005 in Henri Mondor Hospital, 15 isolates (10 A. ursingii and 5 A. schindleri isolates) were studied. They were characterized using a phenotypic approach (API 20 NE and VITEK 2 systems), 16S rRNA gene sequencing, and susceptibility to antimicrobial agents with evaluation of impact in clinical relevance. The two corresponding type strains were also included for comparison. All isolates were identified to the species level using molecular tools, whereas the phenotypic methods remained unreliable due to the absence of these two species in the manufacturers' databases. However, the API 20 NE system appeared to be a reasonably reliable phenotypic alternative for the identification of A. ursingii when the numerical code 0000071 was found. Conversely, no discriminative phenotypic alternative existed for A. schindleri isolates. Concerning antimicrobial susceptibility, A. ursingii strains appeared to be more resistant to antibiotics than A. schindleri strains, which could imply therapeutic consequences. Finally, the prevalence of infections caused by A. ursingii and A. schindleri (representing 9.7% and 4.8% of non-A. calcoaceticus-A. baumannii complex strains, respectively) seems to be underestimated.

* Corresponding author. Mailing address: Laboratoire de Bactériologie-Virologie-Hygiène, Centre Hospitalier Universitaire Henri Mondor, 94010 Créteil Cedex, France. Phone: 33 1 49 81 68 16. Fax: 33 1 49 81 28 39. E-mail: vincent.cattoir{at}hmn.aphp.fr.

{triangledown} Published ahead of print on 18 October 2006.

Journal of Clinical Microbiology, December 2006, p. 4471-4478, Vol. 44, No. 12
0095-1137/06/$08.00+0     doi:10.1128/JCM.01535-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Potron, A., Poirel, L., Croize, J., Chanteperdrix, V., Nordmann, P. (2009). Genetic and Biochemical Characterization of the First Extended-Spectrum CARB-Type ss-Lactamase, RTG-4, from Acinetobacter baumannii. Antimicrob. Agents Chemother. 53: 3010-3016 [Abstract] [Full Text]  
  • Gundi, V. A. K. B., Dijkshoorn, L., Burignat, S., Raoult, D., La Scola, B. (2009). Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 155: 2333-2341 [Abstract] [Full Text]  
  • Figueiredo, S., Poirel, L., Croize, J., Recule, C., Nordmann, P. (2009). In Vivo Selection of Reduced Susceptibility to Carbapenems in Acinetobacter baumannii Related to ISAba1-Mediated Overexpression of the Natural blaOXA-66 Oxacillinase Gene. Antimicrob. Agents Chemother. 53: 2657-2659 [Abstract] [Full Text]  
  • Chen, T.-L., Siu, L.-K., Lee, Y.-T., Chen, C.-P., Huang, L.-Y., Wu, R. C.-C., Cho, W.-L., Fung, C.-P. (2008). Acinetobacter baylyi as a Pathogen for Opportunistic Infection. J. Clin. Microbiol. 46: 2938-2944 [Abstract] [Full Text]  
  • de la Tabla Ducasse, V. O., Gonzalez, C. M., Saez-Nieto, J. A., Gutierrez, F. (2008). First case of post-endoscopic retrograde cholangiopancreatography bacteraemia caused by Acinetobacter ursingii in a patient with choledocholithiasis and cholangitis. J Med Microbiol 57: 1170-1171 [Abstract] [Full Text]  
  • Peleg, A. Y., Seifert, H., Paterson, D. L. (2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21: 538-582 [Abstract] [Full Text]  
  • Poirel, L., Mansour, W., Bouallegue, O., Nordmann, P. (2008). Carbapenem-Resistant Acinetobacter baumannii Isolates from Tunisia Producing the OXA-58-Like Carbapenem-Hydrolyzing Oxacillinase OXA-97. Antimicrob. Agents Chemother. 52: 1613-1617 [Abstract] [Full Text]  
  • Poirel, L., Figueiredo, S., Cattoir, V., Carattoli, A., Nordmann, P. (2008). Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.. Antimicrob. Agents Chemother. 52: 1252-1256 [Abstract] [Full Text]  
  • Kilic, A., Li, H., Mellmann, A., Basustaoglu, A. C., Kul, M., Senses, Z., Aydogan, H., Stratton, C. W., Harmsen, D., Tang, Y.-W. (2008). Acinetobacter septicus sp. nov. Association with a Nosocomial Outbreak of Bacteremia in a Neonatal Intensive Care Unit. J. Clin. Microbiol. 46: 902-908 [Abstract] [Full Text]  
  • Poirel, L., Corvec, S., Rapoport, M., Mugnier, P., Petroni, A., Pasteran, F., Faccone, D., Galas, M., Drugeon, H., Cattoir, V., Nordmann, P. (2007). Identification of the Novel Narrow-Spectrum {beta}-Lactamase SCO-1 in Acinetobacter spp. from Argentina. Antimicrob. Agents Chemother. 51: 2179-2184 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»